MedPath

Roche Diagnostics Gmbh

🇳🇴Norway
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.roche.com

Clinical Trials

7

Active:1
Completed:3

Trial Phases

0 Phases

Drug Approvals

20

PHILIPPINES:10
NMPA:7
SFDA:3

Drug Approvals

Recombinant Human Erythropoietin β Injection (CHO Cell)

Product Name
罗可曼
Approval Number
S20171007
Approval Date
Aug 25, 2017
NMPA

Recombinant Human Erythropoietin β Injection (CHO Cell)

Product Name
罗可曼
Approval Number
S20171009
Approval Date
Aug 25, 2017
NMPA

Bevacizumab Injection

Product Name
安维汀
Approval Number
S20170036
Approval Date
May 8, 2017
NMPA

Rituximab Injection

Product Name
美罗华
Approval Number
国药准字J20170034
Approval Date
Apr 28, 2017
NMPA

Rituximab Injection

Product Name
美罗华
Approval Number
J20170034
Approval Date
Apr 28, 2017
NMPA

Rituximab Injection

Product Name
美罗华
Approval Number
J20170005
Approval Date
Feb 15, 2017
NMPA

Rituximab Injection

Product Name
美罗华
Approval Number
国药准字J20170005
Approval Date
Feb 15, 2017
NMPA

Clinical Trials

Identification of Liver Fibrosis Biomarkers

Not yet recruiting
Conditions
Non-alcoholic Steatohepatitis
Non-Alcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver
First Posted Date
2025-02-11
Last Posted Date
2025-02-11
Lead Sponsor
Roche Diagnostics GmbH
Target Recruit Count
575
Registration Number
NCT06819917

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.